American Journal of Epidemiology and Infectious Disease
ISSN (Print): 2333-116X ISSN (Online): 2333-1275 Website: Editor-in-chief: Apply for this position
Open Access
Journal Browser
American Journal of Epidemiology and Infectious Disease. 2014, 2(4), 88-92
DOI: 10.12691/ajeid-2-4-1
Open AccessCase Study

Antibiotics Susceptibility Patterns of some Uropathogens to Nitrofurantoin and Nalidixic Acid among Pregnant Women with Urinary Tract Infections in Federal Medical Centre, Bida, Niger-State, North Central, Nigeria

Akobi Oliver Adeyemi1, , Emumwen Evbaziegbere Gideon1, Inyinbor Henry Eromosele1, Akobi Evelyn Chimerenma2, Ogedengbe Sunday Oladokun1, Uzoigwe Eunice Ogochukwu1, Abayomi Rachel Olufunmilayo1 and Emumwen Ehiosu Favour3

1Medical Microbiology Department, Federal Medical Centre, Bida, Niger-State

2Nursing Department, Federal Medical Centre, Bida, Niger State

3Medical Laboratory Services, Fed. Polytechnic Medical Centre, Bida, Niger-State

Pub. Date: August 10, 2014

Cite this paper:
Akobi Oliver Adeyemi, Emumwen Evbaziegbere Gideon, Inyinbor Henry Eromosele, Akobi Evelyn Chimerenma, Ogedengbe Sunday Oladokun, Uzoigwe Eunice Ogochukwu, Abayomi Rachel Olufunmilayo and Emumwen Ehiosu Favour. Antibiotics Susceptibility Patterns of some Uropathogens to Nitrofurantoin and Nalidixic Acid among Pregnant Women with Urinary Tract Infections in Federal Medical Centre, Bida, Niger-State, North Central, Nigeria. American Journal of Epidemiology and Infectious Disease. 2014; 2(4):88-92. doi: 10.12691/ajeid-2-4-1


Background: Antimicrobial drug resistance is a worldwide problem that is exacerbated by the diminishing number of new antimicrobial drugs. Developing countries face substantial problems of antimicrobial resistance as a result of emerging and re-emerging resistant organisms. Aim: This study was design to reports on antibiotic susceptibility and resistance pattern of bacteria pathogens of UTIs among pregnant women in Bida, North Central, Nigeria, and to determine the extent of resistance of these bacteria pathogens to these drugs in the community. Materials and Methods: The research was a retrospective studies carried out between August 2012 to December 2013 and were exempted from ethical approval. Five hundred and sixteen (516) bacterial pathogens were selected for this study as isolated at the Medical Microbiology Department of Federal Medical Centre, Bida, Niger State, North Central, Nigeria. Data was coded, computed and analyzed using SPSS version 16.0 and p-values ≤0.05 was considered to be statistically significant. Result: Out of this 516 bacteria isolates, Escherichia coli 342(66.3%) was the most predominant followed by Staphylococcus aureus 162(31.4%), Klebsiella specie 6(1.2%), Serratia marcescens 4(0.8%) and the least prevalence Proteus specie 2(0.4%). Overall susceptibility pattern of uropathogens to Nitrofurantoin was (58.5%) and Nalidixic acid (34.5%) and both were statistically significant (Nitrofurantoin p=0.000, Mean value 75.5 and Nalidixic acid p=0.000, Mean value 44.5). Escherichia coli the highest in predominance shows susceptibility rate of 61.4% and 42.1% to Nitrofurantoin and Nalidixic acid respectively. Conclusion: Routine microbiological analysis and susceptibility test should be carried out before administration of drugs to patient. Government should make policy that will discourage over the counter sales and use of antimicrobials without prescription from authorized Medical personnel.

Antibiotics susceptibility Uropathogen Urinary tract infections

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit


[1]  Spellberg B, Powers J.H, Brass E.P, Miller L.G, Edwards J.E (Jr.): Trends in antimicrobial drug development: implications for the future. Clin. Infect. Dis. 2004, 38: 1279-1286.
[2]  Talbot G.H, Bradley J, Edwards J.E (Jr.), Gilbert D, Scheld M, Bartlett J.G: Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin. Infect. Dis. 2006, 42: 657-668.
[3]  Okonko I.O, Soleye F.A, Amusan T.A, Ogun A.A, Ogunnusi T.A, Ejembi J,: Incidence of Multi-Drug Resistance (MDR) Organisms in Abeokuta, South western Nigeria. Global J. Pharmacol. 2009a, 3 (2): 69-80.
[4]  Byarugaba D.K. A,: View on antimicrobial resistance in developing countries and responsible risk factors. Int. J, Antimicrob Agents. 2004, 24: 105-10.
[5]  Okeke I.N, Lamikanra A, Edelman R. (1999); Socioeconomic and behavioural factors leading to acquired bacterial resistance to antibiotics in developing countries. Emerg Infect Dis. 1999, 5: 18-27.
[6]  Okeke I.N, Aboderin O.A, Byarugaba D.K, Ojo K.K, Opintan J.A: Growing problem of multidrug-resistant enteric pathogens in Africa. Emerg. Infect. Dis. 2007, [cited 2009 August 18]. Available from
[7]  Okonko I.O, Donbraye-Emmanuel O.B, Ijandipe L.A, Ogun A.A, Adedeji A.O, Udeze A.O,: Antibiotics Sensitivity and Resistance Patterns of Uropathogens to Nitrofurantoin and Nalidixic Acid in Pregnant Women with Urinary Tract Infections in Ibadan, Nigeria. Middle-East J. Sci. Res. 2009b, 4 (2): 105-109.
[8]  Eggleston K, Ruifang Z, Richard J,: The Global Challenge of Antimicrobial Resistance: Insights from Economic Analysis. Int. J. Environ. Res. Public Health, 2010, 7, 3141-3149.
[9]  Vialle-Valentin C.E, LeCates R.F, Zhang F, Desta A, Ross-Degnan D,: Predictors of antibiotic use in African communities: evidence from medicines household surveys in five Countries. Tr. Med Int Health; 2012, 17 (2): 211-222.
[10]  Kunin C.M,; Resistance to antimicrobial drugs-a worldwide calamity. Ann Intern Med. 1993, 118: 557-61.
[11]  Rao G.G,: Risk factors for the spread of antibiotic-resistant bacteria. Drugs; 1998, 55 (3): 323-30.
[12]  Okeke I.N, Laxminarayan R, Bhutta Z.A, Duse A.G, Jenkins P, O‘Brien TF, Pablos MA, Klugman K.P,: Antimicrobial resistance in developing countries: Recent trends and current status. Lancet Infect. Dis. 2005, 5, 481-493.
[13]  United States Agency for International Development (USAID),: Bureau for Africa, Office of Sustainable Development. The Health Sector Human Resource Crisis in Africa: 2003 An Issues Paper.
[14]  Peti Ca, Polage CR, and Quinn T,: Laboratory medicine in Africa: barrier to effective health care. Clin Infect Dis. 2006, 42: 377-382.
[15]  Ezeala C.C,: Skilling-up medical laboratory technologists for Higher Roles in Biomedical Sciences: A needs analysis. African Journal of Health Professions Education. 2011, 3 (2).
[16]  Okonko, I.O, Ijandipe L.A, Ilusanya A.O, Donbraye-Emmanuel O.B, Ogun A.A, Akanbi O.A, Ejembi J and Faleye T.O.C,: Detection of Urinary Tract Infection (UTI) among Pregnant Women in Oluyoro Catholic Hospital, Ibadan, South-Western, Nigeria. Malaysian J. Microbiol. 2009, (in press).
[17]  Elhag, K.M. and Chug T.D,: Bacteriuria in the Arabian Gulf. Arab. J.Med., 1982, 1: 5, 10.
[18]  Baerheim A,: Empirical treatment of uncomplicated cystitis. BMJ. 2001, 323: 1197-1198.
[19]  Gupta K, Hooton T.M, Stamm W.E, Increasing antimicrobial resistance and the management of uncomplicated community acquired urinary tract infections. Ann Intern Med, 2001, 135: 41-50.
[20]  Johnson J.R, Schaeffer A.J, Stamm,: Guidelines for the treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis; 1999, 29: 745 58.
[21]  McNulty C.A.M, Richards J and Livermore D.M,: Clinical relevance of laboratory reported antibiotic resistance in acute uncomplicated urinary tract infection in primary care. J Antimicrob Chemother; 2006, 58:1000-8.
[22]  Alam M.F, Cohen D and Butler C,: The additional costs of antibiotics and re-consultations for antibiotic-resistant Escherichia coli urinary tract infections managed in general practice. Int J Antimicrob Agents; 2009, 33: 255-7.
[23]  Zhanel G.G, Hisanaga T.L and Laing N.M, (2006) Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Int J Antimicrob Agents; 27: 468-75.
[24]  Kolawale A.S, Kolawale O.M and Kandaki-Olukemi Y.T,: Prevalence of Urinary Tract Infections among Patients Attending Dalhatu Araf Specialist Hospital, Lafia, Nasarawa State, Nigeria,” International Journal of Medical Sciences, 2009, Vol. 1, No. 5, pp. 163-167.
[25]  Hvidberg H, Struve C, and Krogfelt K.A,: Development of a Long-Term Ascending Urinary Tract Infection Mouse Model for Antibiotic Treatment Studies, Antimicrobial Agents and Chemotherapy, 2000, Vol. 44, No. 1, 2000, pp. 156-163.
[26]  Mohemid M. Al-Jebouri, and Salih A. Mdish,: Antibiotic Resistance Pattern of Bacteria Isolated from Patients of Urinary Tract Infections in Iraq. Open Journal of Urology, 2013, Vol. 3, pp. 124-131. Published Online May 2013 (
[27]  Assefa A, Asrat D, Woldeamanuel Y, G/Hiwot Y, Abdella A, Melesse T: Bacterial profile and drug susceptibility pattern of urinary tract infection in pregnant women at Tikur Anbessa Specialized Hospital Addis Ababa, Ethiopia. Ethiopia Medical Journal, 2008, 46: 227-235.
[28]  Mokube MN, Atashili J, Halle-Ekane GE, Ikomey GM, Ndumbe PM,: Bacteriuria amongst Pregnant Women in the Buea Health District, Cameroon: Prevalence, Predictors, Antibiotic Susceptibility Patterns and Diagnosis. PLoS ONE 2013, 8 (8): e71086.
[29]  Onoh R.C, Umeora O.U.J, Egwuatu V.E, Ezeonu P.O, Onoh T.J.P,: Antibiotics sensitivity pattern of uropathogens from pregnant women with urinary tract infection in Abakaliki, Nigeria. Journal of infection and drug resistance, 2013, vol. (6), p. 225-233.
[30]  David C. Bean, Daniel Krahe, David W. Wareham,: Antimicrobial resistance in community and nosocomial Escherichia coli urinary tract isolates, London 2005-2006, Annals of clinical microbiology and antimicrobials, 2008, vol. (7): 13.
[31]  Okonko I.O, Donbraye-Emmanuel O.B, Ijandipe L.A, Ogun A.A, Adedeji A.O, and Udeze A.O,: Antibiotics sensitivity and resistance patterns of uropathogens to Nitrofurantoin and Nalidixic acid in pregnant women with urinary tract infections in Ibadan,Nigeria. Middle East Journal of Scientific Research, 2009, 4 (2): 105-109.
[32]  Kalantar Enayat, Farhadifar Fariba and Nikkho Bahram,: Asymptomatic Bacteriuria among Pregnant Women Referred to Outpatient Clinics in Sanandaj, Iran. International Braz., J. Urol, 2008, Vol. 34 (6): 699-707.
[33]  Mohemid M. Al-Jebouri and Salih A. Mdish,: Antibiotic Resistance Pattern of Bacteria Isolated from Patients of Urinary Tract Infections in Iraq. Open Journal of Urology, 2013, vol. 3, 124-131.
[34]  Igwegbe A.O, Ugboaja J.O and Okoli O.A,: Prevalence of asymptomatic bacteriuria among pregnant women in Nnewi, southeast Nigeria. Int. J. Biol. Chem. Sci. 2012, 6 (1): 88-98.
[35]  Sevki Celen, Ayla Sargin Oruc¸ Rana Karayalcin, Sibel Saygan, Serpil Unlu, Belgin Polat and Nuri Danisman,:Asymptomatic Bacteriuria and Antibacterial Susceptibility Pattern in an Obstetric Population. ISRN Obstetrics and Gynecology, 2011, Vol. 2011, Article ID 721872, 4 pages.
[36]  Awonuga D.O, Dada-Adegbola H.O, Fawole A.O, Olola F. O, Awonuga O.M and Onimisi-Smith H.O,: Asymptomatic Bacteriuria among an Obstetric Population in Ibadan. WAJM; 2011, 30 (2): 89-93.
[37]  Iram Shaifali, Uma Gupta, Syed Esam Mahmood and Jawed Ahmed,: Antibiotic Susceptibility Patterns of Urinary Pathogens in Female Outpatients. North American Journal of Medical Sciences, 2012, Vol., (4) Issue 4.
[38]  Das R.N, Chandrashekhar T.S, Joshi H.S, Gurung M, Shrestha N, and Shivananda P.G,: Frequency and susceptibility profile of pathogens causing urinary tract infections at a tertiary care hospital in western Nepal. Singapore Med., J; 2006, 47 (4): 281.
[39]  Lin-Hui Su, Jonathan T. Ou, Hsieh-Shong Leu, Ping-Cherng Chiang, Yueh-Pi Chiu, Ju-Hsin Chia, An-Jing Kuo, Cheng-Hsun Chiu, Chishih Chu, Tsu-Lan Wu, Chien-Feng Sun, Thomas V. Riley and Barbara J. Chang,: Extended Epidemic of Nosocomial Urinary Tract Infections Caused by Serratia marcescens. J. Clinical Microbiology, 2003, p. 4726-4732.
[40]  Onifade, A.K., Omoya F.O and Adegunloye D.V,: Incidence and control of urinary tract infections among pregnant women attending antenal clinics in government hospitals in Ondo State, Nigeria. J. Food, Agric. Environ., 2005, Vol. 3 (1): 37-38.
[41]  Stanley Chukwudozie Onuoha and Kayode Fatokun,: Prevalence and antimicrobial susceptibility pattern of Urinary Tract Infection among pregnant women in Afikpo, Ebonyi State, Nigeria. American Journal of Life Sciences; 2014, 2 (2): 46-52.
[42]  Akinola B. Ajayi, Charles Nwabuisi, Abiodun P. Aboyeji, Nanji S. Ajayi, Adeola Fowotade and Olurotimi O. Fakeye,: Asymptomatic Bacteriuria in Antenatal Patients in Ilorin, Nigeria. Oman Medical Journal, 2012, Vol. 27, No. 1: 31-35.
[43]  Selimuzzaman A.B M, Ullah M.A and Haque M.J,: Asymptomatic Bacteriuria during Pregnancy:Causative Agents and Their Sensitivity in Rajshahi City. The Journal of Teachers Association RMC, Rajshahi, 2006, 19 (2): 66-69.
[44]  May Mohamed Ali,: Evaluation of antimicrobial susceptibility & rapid urine screening tests in asymptomatic urinary tract infection in pregnant women in Karbala. Karbala Journal of Pharmaceutical Sciences. 2011, Number 2.
[45]  Karlowsky J.A, Jones M.E, Thornsberry C, Critchley I, Kelly L, Sahm D,: Prevalence of antimicrobial resistance among pathogens isolated from female outpatients across the US in 1999. Int. J. Antimicrob. Agents. 2001, 18: 121-127.
[46]  Gales A.C, Sader H.S and Jones R.N,: Urinary tract infection trends in Latin American hospitals: report from the SENTRY antimicrobial Surveillance program (1997-2000). Diagn. Microbiol. Infect. Dis. 2002, 44: 289-299.
[47]  Blondeau J.M and Tillotson G.S,: Formula to help select rational antimicrobial therapy (FRAT): its application to community and hospital-acquired urinary tract infections. Int. J. Antimicrob. Agents. 1999, 12: 145-150.
[48]  Onuoha Stanley Chukwudozie and Fatokun Kayode: Prevalence and antimicrobial susceptibility pattern of Urinary Tract Infection (UTI) among pregnant women in Afikpo, Ebonyi State, Nigeria. American Journal of Life Sciences; 2014, 2 (2): 46-52. (
[49]  Rahman Farjana, Chowdhury Sadia, Rahman Majibur Md., Ahmed Dilruba and Hossain Anowar,: Antimicrobial Resistance Pattern of Gram-negative Bacteria Causing Urinary Tract Infection. S. J. Pharm. Sci. 2009, 2 (1): 44-50.